Method for in vitro amplification of hemopoietic stem cells and precursor cells

A precursor cell, in vitro expansion technology, applied in the direction of blood/immune system cells, animal cells, vertebrate cells, etc., can solve the problem of defining the elements that hinder the developmental stage of hematopoietic stem cells, difficult to make substantial improvements, and limiting stem cells and precursors Cell applications, etc.

Active Publication Date: 2010-06-16
杭州中赢生物医疗科技有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This complex microenvironment also greatly hinders the definition of elements that affect the developmental stages of hematopoietic stem cells
Although first-generation stromal co-culture systems were able to sustain long-term production of stem cells, these stem cells are currently difficult to use for therapeutic purposes
First, the cellular microenvironment in this system is very complex and difficult to substantia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for in vitro amplification of hemopoietic stem cells and precursor cells
  • Method for in vitro amplification of hemopoietic stem cells and precursor cells
  • Method for in vitro amplification of hemopoietic stem cells and precursor cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1 Stem Cell Expansion

[0039] Human bone marrow cells and human peripheral blood cells were obtained from healthy donors. Methods for extracting CD34-positive stem and precursor cells are well known to those with basic skills in the industry. Firstly, the density gradient centrifugation method was used to separate the lymphocytes from human bone marrow cells and human peripheral blood cells. CD34-positive bone marrow stem and precursor cells were further purified using the antibody magnetic bead method.

[0040] After the stem cells are purified through this process, monitoring by flow cytometry shows that their purity exceeds 99%. The isolated and purified CD34-positive stem cells and precursor cells can be frozen and stored in liquid nitrogen for a long time (1 million to 5 million cells / ml). Frozen cells can be quickly thawed in a 37°C water bath, washed twice with medium, and trypan blue staining shows that 99% of the cells are still alive.

[0041] The...

Embodiment 2

[0047] Embodiment 2 mouse transplantation

[0048] Female mice aged 12-14 weeks (C57BL / 6) were purchased from Jackson Laboratory, USA. Animals were maintained on a 12 hr light / dark cycle. HUVEC cells were cultured for 7 days after adding IMDM. Add 10% inactivated fetal bovine serum (FBS) and 1% penicillin to IMDM.

[0049] In vitro expansion of bone marrow cells

[0050] Mouse stem cells were isolated from femoral bone marrow cells. The isolated stem cells were seeded into culture dishes filled with HUVECs. After adding GM-CSF (5ng / ml) and IL-3 (5ng / ml) at 37°C and 5% carbon dioxide for 7 days, gently remove non-adherent cells from the HUVEC layer. Wash with PBS containing 1% FBS and 1% penicillin, and concentrate.

[0051] Mice were sacrificed by cervical dislocation, and femurs and spleens were removed. Cells in the femur were washed with 5 ml of PBS containing 10% heat-inactivated fetal bovine serum. Break up the spleen tissue with a 25-gauge needle until the cells ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for in vitro amplification of stem cells, in particular a method for amplifying the hemopoietic stem cells and the precursor cells by co-culturing hemopoietic stem cells and precursor cells, which are separated from human peripheral blood or marrow, and endothelial cells. The method comprises the following steps of: separating the CD34 positive marrow stem cells and precursor cells; making the stem cells and the precursor cells directly contacted with the endothelial cells for culture; adding at least one type of cytokine to amplify the stem cells and the precursor cells; and recognizing the stem cells and the precursor cells by the cell surface antigens, and selecting the stem cells and the precursor cells, which have positive CD34 negative CD38, negative HLA-DR, negative CD15, negative Lin, positive c-kit, and no less than 85 percent purity. The method has the advantages of having good cell amplification effect, obviously reducing the drawing amount of the marrow and peripheral blood of a patient, lowering the necessity of general anaesthesia, enforcing quick recovery of hemopoiesis, and shortening the time when the patient stays in the hospital. The method has a wide application prospect in disease treatment.

Description

technical field [0001] The invention relates to a method for expanding stem cells in vitro, in particular to a method for co-culturing hematopoietic stem cells and precursor cells isolated from human peripheral blood or bone marrow with endothelial cells to expand hematopoietic stem cells and precursor cells. technical background [0002] The formation of mature blood cells is a very complex process, and the process of blood cell maturation mainly occurs in the bone marrow. Hematopoietic stem cells proliferate and differentiate to produce different types of mature blood cells. Hematopoietic stem and precursor cells have extensive and long-term self-renewal capabilities and the ability to differentiate into all lymphocytes. CD34-labeled hematopoietic cell surface antigen is an important marker of hematopoietic stem and precursor cells. 1-5% of cells in bone marrow express CD34 antigen, and 0.1-0.5% of cells in peripheral blood express CD34 antigen. CD34 antigen is also exp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/0775C12N5/0789
Inventor 徐以兵吴忠福董升炬
Owner 杭州中赢生物医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap